Podcast thumbnail for 牛白丁

by 华创资本

65 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇨🇳

Podcast Overview

《牛白丁》是由华创资本出品的一档播客节目,在这里,你将听到来自华创资本和我们的朋友们,以投资人和创业者的第一视角,一起交流那些投资、创业、前沿科技、消费、生命科学等领域的洞察和趋势,回忆片段与瞬间,剖析认知和思考。 华创资本是一家专注交叉科技前沿生产力的早期投资者,自2014年成立基金迄今,累计管理近百亿资产,相继在前沿科技与生命科学领域投资了超过200家公司,在从外太空(蓝箭航天、星思半导体)到单细胞多组学(新格元),从无人驾驶(文远知行、智加科技和图达通)到下一代计算架构(深鉴科技(赛灵思NASDAQ: XLNX收购)、PingCAP、ScaleFlux、壁仞科技),从手术机器人(华科精准、Noah Medical)到蛋白质测序(Rapid Novor)等领域,是诸多业界领先公司的早期支持者。

Language

🇨🇳

Publishing Since

5/31/2023

1 verified contact email on file for 牛白丁

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for 公大激光数亿C轮融资:绿光激光与铜基3D打印奔赴AI算力

May 12, 2026

公大激光数亿C轮融资:绿光激光与铜基3D打印奔赴AI算力

<p>近日,深圳<a target="_blank" rel="noopener noreferrer nofollow" class="normal_text_link mp_article_text_link" href="https://mp.weixin.qq.com/s?__biz=MzA4MzA3MzYxMQ==&amp;mid=2662446460&amp;idx=1&amp;sn=64f8d7bf15546f39e4e956207c12a4d6&amp;scene=21#wechat_redirect"><strong>公大激光</strong></a>有限公司宣布完成数亿元C轮战略融资。本轮融资<strong>华创资本继续加注跟投</strong>,达晨财智、光合创投联合领投,禾创致远(中际旭创关联基金)、华胥基金(三一集团关联基金)、力合资本多家产业资本共同参与。本轮投资方阵容覆盖头部财务投资机构、产业龙头企业及硬科技产业资本,形成“资本+产业+技术”的综合投资组合。</p><p><a target="_blank" rel="noopener noreferrer nofollow" class="normal_text_link mp_article_text_link" href="https://mp.weixin.qq.com/s?__biz=MzA4MzA3MzYxMQ==&amp;mid=2662436612&amp;idx=1&amp;sn=7ad4f085353e9c1cb895382b59859076&amp;scene=21#wechat_redirect"><strong>此前,华创资本曾在A轮投资了公大激光。</strong></a></p><p>公大激光是全球首家实现4kW准单模连续绿光激光器的公司,代表了当前绿光激光器的全球最高水平。自研绿光激光器已实现在锂电、半导体制造以及高端设备制造领域大批量规模化的出货。</p><p>🪔<strong>【温馨提示】</strong></p><p>阅读每期节目完整文字稿,请移步微信公众号<strong>「华创资本」</strong></p><p><strong>【免责声明】</strong></p><p>本播客所述投资相关内容皆以交流分享为目的,仅供参考,不构成任何市场预测、判断,或投资、咨询、法律等建议。</p><p>*本期节目声音尝试用ListenHub制作生成</p>

Episode thumbnail for 炜璨医疗李强:从理解规则,到建立规则——重塑植入式给药路径

April 23, 2026

炜璨医疗李强:从理解规则,到建立规则——重塑植入式给药路径

<p>30岁那年,医生李强从上海九院辞职,去辉瑞做起了药代。</p><p>拿下第一单后,涌上来的只有屈辱和崩溃,那是他用尊严换来的。</p><p>此后三年,他反复拷问自己这一步的选择,直到赚到第一桶金,也逐渐意识到这份工作的价值——推动医疗行业向前走的,从来不只是医生,更重要的还有企业。</p><p>只有看清一个行业的规则是如何制定的,才有可能重新改写它。</p><p>在民企期间,他发现了创业机会,从输液港这个赛道切入,成立炜璨医疗,建立起一套全新的植入式给药解决方案。</p><p>从医生到销售、从外企到民企,李强不断进入新的系统,习得“游戏规则”,理解它、适应它。</p><p>直到这次创业,他决定成为规则的改写者。</p><p>近日,「创·问」编辑部对话了炜璨医疗创始人、董事长李强。</p><p>炜璨医疗是目前全球首个涵盖静脉、动脉、脊柱、腹腔、透析、颅内等全场景植入式给药装置+智能化植入式自体给药装置的创新型医疗器械公司,公司依靠自研团队开发的多种植入式给药装置系列产品,均为国内外首创。</p><p><strong>2023年,华创资本在种子轮独家投资了炜璨医疗,并在后续融资中持续加注。</strong></p><p>🛋️<strong>【本期嘉宾】</strong></p><p><strong>李强,</strong>炜璨医疗创始人、董事长。华中科技大学同济医学院临床医学本科、香港理工大学硕士。近 20 年职业生涯,从上海九院临床一线起步,先后在辉瑞、美敦力、贝朗等国际顶尖外企历练,曾任科睿驰医疗利润中心负责人,两次从零搭建团队与营销管理体系。</p><p>🎙️<strong>【本期主播】</strong></p><p>华创资本<a target="_blank" rel="noopener noreferrer nofollow" href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA4MzA3MzYxMQ==&amp;action=getalbum&amp;album_id=1539525492146552833&amp;scene=126#wechat_redirect">「创·问」编辑部</a></p><p>🪔<strong>【温馨提示】</strong></p><p>阅读每期节目完整文字稿,请移步微信公众号<a target="_blank" rel="noopener noreferrer nofollow" href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA4MzA3MzYxMQ==&amp;action=getalbum&amp;album_id=1936948340806500355&amp;scene=126#wechat_redirect">「华创资本」</a></p><p><strong>【免责声明】</strong></p><p>本播客所述投资相关内容皆以交流分享为目的,仅供参考,不构成任何市场预测、判断,或投资、咨询、法律等建议。</p>

Episode thumbnail for 半年内连融三轮,庞伯特用AI定义体育运动新范式

April 14, 2026

半年内连融三轮,庞伯特用AI定义体育运动新范式

<p>近日,庞伯特宣布在不到半年时间里,连续完成了三轮累计近两亿元的A轮系列融资,<strong>华创资本</strong>、神骐资本、明势创投、蓝驰创投、锦秋基金等头部机构集体加注。本轮融资将重点投入产品技术迭代,同时加速推进全球化品牌与市场布局。</p><p><br>庞伯特品牌背后的上海创屹科技有限公司,是国家级高新技术企业、上海市专精特新企业、上海市智能机器人标杆企业。公司依托乒乓球场景完成底层技术验证后,快速向包含网球在内的隔网球品类赛道拓展,并进行全球化业务布局,现已覆盖专业体育训练至家庭娱乐全场景,构建起“技术可复用、市场全球化”的核心竞争壁垒。</p><p><br></p><p>🪔【温馨提示】</p><p><br></p><p>阅读每期节目完整文字稿,请移步微信公众号<a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA4MzA3MzYxMQ==&amp;action=getalbum&amp;album_id=1936948340806500355&amp;scene=126#wechat_redirect">「华创资本」</a></p><p><br></p><p>【免责声明】</p><p><br></p><p>本播客所述投资相关内容皆以交流分享为目的,仅供参考,不构成任何市场预测、判断,或投资、咨询、法律等建议。</p><p><br></p><p>*本期节目声音尝试用ListenHub制作生成<br></p>

65 total episodes available

Deep-dive analytics for 牛白丁

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is 牛白丁?

《牛白丁》是由华创资本出品的一档播客节目,在这里,你将听到来自华创资本和我们的朋友们,以投资人和创业者的第一视角,一起交流那些投资、创业、前沿科技、消费、生命科学等领域的洞察和趋势,回忆片段与瞬间,剖析认知和思考。

华创资本是一家专注交叉科技前沿生产力的早期投资者,自2014年成立基金迄今,累计管理近百亿资产,相继在前沿科技与生命科学领域投资了超过200家公司,在从外太空(蓝箭航天、星思半导体)到单细胞多组学(新格元),从无人驾驶(文远知行、智加科技和图达通)到下一代计算架构(深鉴科技(赛灵思NASDAQ: XLNX收购)、PingCAP、ScaleFlux、壁仞科技),从手术机器人(华科精准、Noah Medical)到蛋白质测序(Rapid Novor)等领域,是诸多业界领先公司的早期支持者。

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.